US2023295643A1PendingUtilityA1
Curing for recursive nucleic acid-guided cell editing
Est. expiryJun 6, 2039(~12.9 yrs left)· nominal 20-yr term from priority
C12N 9/22C12N 15/70C12N 15/635C12N 2310/20C12N 15/111C12N 15/113C12N 2800/80
84
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides automated multi-module instrumentation and automated methods for performing recursive editing of live cells with curing of editing vectors from prior rounds of editing.
Claims
exact text as granted — not AI-modified1 . A composition of matter for recursive nucleic acid-directed nuclease CRISPR editing comprising:
a first vector comprising:
an origin of replication;
one or more editing gRNA and donor DNA pairs under the control of a first inducible promoter, wherein the editing gRNA and donor DNA pairs edit target sequences in a cell;
a curing target sequence, wherein the curing target sequence is cut to cleave the vector;
a first selectable marker; and
a second vector comprising:
a second selectable marker; and
a curing gRNA sequence under the control of a second inducible promoter, wherein the curing gRNA targets the curing target sequence on the first vector.
2 .- 25 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.